VALENTINA MOLTENI,HANK MICHAEL JAMES PETRASSI,XIAOLIN LI,XIAODONG LIU,JON LOREN,JULIET NABAKKA,BAO NGUYEN,VINCE YEH
申请号:
PT12756885
公开号:
PT2751104T
申请日:
2012.08.29
申请国别(地区):
PT
年份:
2019
代理人:
摘要:
The invention provides compounds and pharmaceutical compositions thereof, which are useful as protein kinase inhibitors, as well as methods for using such compounds to treat, ameliorate or prevent a condition associated with abnormal or deregulated kinase activity. In some embodiments, the invention provides methods for using such compounds to treat, ameliorate or prevent diseases or disorders that involve abnormal activation of c-kit or c-kit and PDGFR (PDGFRalpha, PDGFRbeta) kinases.